J. D. Geratz

1.3k total citations
51 papers, 1.1k citations indexed

About

J. D. Geratz is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, J. D. Geratz has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Organic Chemistry and 16 papers in Epidemiology. Recurrent topics in J. D. Geratz's work include Peptidase Inhibition and Analysis (9 papers), Enzyme function and inhibition (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). J. D. Geratz is often cited by papers focused on Peptidase Inhibition and Analysis (9 papers), Enzyme function and inhibition (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers). J. D. Geratz collaborates with scholars based in United States, Netherlands and Mexico. J. D. Geratz's co-authors include Richard R. Tidwell, R R Tidwell, Edward J. Dubovi, James Edwin Hall, Kwasi A. Ohemeng, Susan Jones, Sammy R. Shaver, Otto Dann, Michael Cory and Richard F. Parrish and has published in prestigious journals such as Journal of Clinical Investigation, FEBS Letters and Annals of the New York Academy of Sciences.

In The Last Decade

J. D. Geratz

49 papers receiving 982 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. D. Geratz United States 20 332 317 311 226 133 51 1.1k
D. B. Thomas Tanzania 24 881 2.7× 186 0.6× 362 1.2× 123 0.5× 153 1.2× 69 1.9k
Ronald B. Faanes United States 14 442 1.3× 211 0.7× 208 0.7× 508 2.2× 95 0.7× 35 1.6k
André Kirn France 26 523 1.6× 291 0.9× 611 2.0× 755 3.3× 82 0.6× 57 2.0k
Monique Clément France 12 381 1.1× 161 0.5× 157 0.5× 696 3.1× 121 0.9× 15 1.5k
M. A. Chirigos United States 18 344 1.0× 95 0.3× 131 0.4× 95 0.4× 281 2.1× 86 1.3k
Richard D. Head United States 9 590 1.8× 83 0.3× 309 1.0× 293 1.3× 236 1.8× 13 1.6k
Hà Phạm United States 17 944 2.8× 211 0.7× 357 1.1× 412 1.8× 155 1.2× 37 1.5k
Jean‐Michel Bruneau France 15 602 1.8× 72 0.2× 190 0.6× 251 1.1× 130 1.0× 19 1.3k
A. R. Sanderson United Kingdom 23 733 2.2× 114 0.4× 273 0.9× 91 0.4× 149 1.1× 58 1.7k
Thomas C. Warren United States 19 579 1.7× 126 0.4× 74 0.2× 304 1.3× 187 1.4× 27 1.3k

Countries citing papers authored by J. D. Geratz

Since Specialization
Citations

This map shows the geographic impact of J. D. Geratz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. D. Geratz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. D. Geratz more than expected).

Fields of papers citing papers by J. D. Geratz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. D. Geratz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. D. Geratz. The network helps show where J. D. Geratz may publish in the future.

Co-authorship network of co-authors of J. D. Geratz

This figure shows the co-authorship network connecting the top 25 collaborators of J. D. Geratz. A scholar is included among the top collaborators of J. D. Geratz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. D. Geratz. J. D. Geratz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keene, Bruce W., et al.. (1999). ECG changes after rabbit coronavirus infection. Journal of Electrocardiology. 32(1). 21–32. 13 indexed citations
2.
Geratz, J. D., Katherine B. Pryzwansky, S K Anderle, & Richard R. Tidwell. (1995). Control of glucan-induced systemic granulomatosis by cyclosporine A. Inflammation. 19(2). 221–231. 6 indexed citations
3.
Geratz, J. D., KB Pryzwansky, John H. Schwab, S K Anderle, & R R Tidwell. (1993). Suppression of local and systemic responses in streptococcal cell wall-induced acute inflammation of the air pouch by cyclosporine A. Comparison with the effects of two anti-inflammatory bis-benzimidazoles.. PubMed. 142(4). 1227–37. 6 indexed citations
4.
Tidwell, Richard R., Susan Jones, J. D. Geratz, et al.. (1990). Development of Pentamidine Analogues as New Agents for the Treatment of Pneumocystis carinii Pneumoniaa. Annals of the New York Academy of Sciences. 616(1). 421–441. 41 indexed citations
5.
Tidwell, R R, Susan Jones, J. D. Geratz, et al.. (1990). Analogs of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. Journal of Medicinal Chemistry. 33(4). 1252–1257. 120 indexed citations
6.
Geratz, J. D., R R Tidwell, John H. Schwab, S K Anderle, & KB Pryzwansky. (1990). Sequential events in the pathogenesis of streptococcal cell wall-induced arthritis and their modulation by bis(5-amidino-2-benzimidazolyl)methane (BABIM).. PubMed. 136(4). 909–21. 18 indexed citations
7.
Jones, Susan, James Edwin Hall, Kwasi A. Ohemeng, et al.. (1990). Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy. 34(6). 1026–1030. 53 indexed citations
8.
Tidwell, Richard R., et al.. (1989). Treatment of Experimental Pneumocystis carinii Pneumonia with Analogs of Pentamidine. The Journal of Protozoology. 36(1). 74S–76S. 12 indexed citations
9.
Tidwell, Richard R., et al.. (1989). Treatment of Experimental Pneumocystis carinii Pneumonia with Analogs of Pentamidine. The Journal of Protozoology. 36(s1). 4 indexed citations
10.
Vonderfecht, Steven, et al.. (1988). Protease inhibitors suppress the in vitro and in vivo replication of rotavirus.. Journal of Clinical Investigation. 82(6). 2011–2016. 33 indexed citations
11.
Geratz, J. D., Katherine B. Pryzwansky, John H. Schwab, S K Anderle, & Richard R. Tidwell. (1988). Suppression of streptococcal cell wall–induced arthritis by a potent protease inhibitor, bis(5‐amidino‐2‐benzimidazolyl)methane. Arthritis & Rheumatism. 31(9). 1156–1164. 9 indexed citations
12.
Askin, Frederic B., et al.. (1987). Angiosarcoma of the Uterus. International Journal of Gynecological Pathology. 6(2). 176–184. 24 indexed citations
13.
Walker, David H., et al.. (1984). Effect of synthetic protease inhibitors of the amidine type on cell injury by Rickettsia rickettsii. Antimicrobial Agents and Chemotherapy. 25(5). 582–585. 20 indexed citations
14.
Dubovi, Edward J., J. D. Geratz, & Richard R. Tidwell. (1983). Enhancement of respiratory syncytial virus-induced cytopathology by trypsin, thrombin, and plasmin. Infection and Immunity. 40(1). 351–358. 22 indexed citations
15.
Parrish, Richard F., et al.. (1978). Structure-activity relationships for the inhibition of acrosin by benzamidine derivatives. Journal of Medicinal Chemistry. 21(11). 1132–1136. 17 indexed citations
16.
Tidwell, R R, et al.. (1976). Aromatic Tris-amidines. Biochimica et Biophysica Acta (BBA) - Enzymology. 445(3). 729–738. 15 indexed citations
18.
Geratz, J. D.. (1970). Inhibition of Thrombin, Plasmin and Plasminogen Activation by Amidino Compounds. Thrombosis and Haemostasis. 23(3). 486–499. 9 indexed citations
19.
Geratz, J. D.. (1969). Inhibitory effect of aromatic diamidines on trypsin and enterokinase. Cellular and Molecular Life Sciences. 25(12). 1254–1255. 19 indexed citations
20.
Geratz, J. D.. (1968). Failure of a Potent Trypsin Inhibitor to Modify Experimental Pancreatitis in Dogs. Archives of Surgery. 96(3). 450–450. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026